Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
Data were collected from 39 newborn screening (NBS) programs to provide insight into the time and factors required for implementing statewide screening for Pompe, Mucopolysaccharidosis type I (MPS I), adrenoleukodystrophy (ALD), and Spinal Muscular Atrophy (SMA). Newborn screening program readiness...
Saved in:
Main Authors: | Yvonne Kellar-Guenther (Author), Sarah McKasson (Author), Kshea Hale (Author), Sikha Singh (Author), Marci K. Sontag (Author), Jelili Ojodu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
by: Kshea Hale, et al.
Published: (2020) -
Development of National Newborn Screening Quality Indicators in the United States
by: Careema Yusuf, et al.
Published: (2019) -
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018-2021
by: Kshea Hale, et al.
Published: (2021) -
Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs
by: Yvonne Kellar-Guenther, et al.
Published: (2019) -
Infants with Congenital Diseases Identified through Newborn Screening-United States, 2018-2020
by: Amy Gaviglio, et al.
Published: (2023)